XtalPi-backed INFevo raises over RMB 100M Pre-A, a record for virtual cell startups
智东西 · wechat · 2026-11-16
INFevo, an AI drug-discovery startup incubated by XtalPi, closed a Pre-A round above RMB 100M ($14M), a single-round record for Chinese virtual cell startups and its second raise in five months. Backers include Starlink Capital and Prosperity7 Ventures, plus angel investors Shunwei, Sequoia China, and Songhe.
Founded in 2025, INFevo builds AI virtual cell models and automated experiment pipelines. Its OCDISTRICTOO-T model predicts gene-expression changes from drug/genetic perturbations, topping STATE and PerturbDiff on Tahoe100M, Replogle, and PBMC benchmarks. It also launched the TPP hypothesis-mining engine and KarlWorkbench, which scored SOTA on SciAgentArena for single-cell and spatial omics using DeepSeek.
The piece notes Google DeepMind, Isomorphic Labs, and Meta committed $300M to Biohub's virtual biology program, while domestic startups DeepCell and MetaCell also raised RMB 100M each.
More from Venture
- Blue Origin raised $38B vs SpaceX's $12B, yet has 3 orbital launches to SpaceX's 716 — XFreeze · 2026-11-16
- Michael Rubin: I was hours, not months, from being wiped out in 2008 — davidsenra · 2026-11-16
- Sequoia and Walleye Capital debate what the AI market gets wrong at Every's Thesis 2027 — every · 2026-11-16
- 100 apps that hit $100K MRR in 12 months: 43 of 94 grew via organic short-form video — alex_verem · 2026-11-16
- Morgan Stanley goes "Max Overweight" on global equities, betting AI capex sustains earnings into 2027 — demian_ai · 2026-11-16
- Investor seals one-year Nvidia prediction behind SHA-256 hash until 2027 — StewartalsopIII · 2026-11-16